Manufacturing and Production

Showing 15 posts of 5872 posts found.

Gilead image

EU approval for Gilead’s HIV combo Genvoya

December 1, 2015 Manufacturing and Production, Sales and Marketing European Commission, Genvoya, Gilead, Gilead Sciences, HIV, TDF, World Aids Day, european union, taf

Gilead Sciences has won marketing authorisation from the European Commission (EC) for the once-daily single tablet regimen Genvoya as an …
Empliciti logo

FDA approves BMS and AbbVie’s Empliciti for multiple myeloma

December 1, 2015 Manufacturing and Production, Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, Empliciti, FDA, elotuzumab, multiple myeloma

The US healthcare regulator has approved Empliciti – a multiple myeloma treatment co-developed by Bristol-Myers Squibb and AbbVie. The FDA …

Laying bare the complexities of the pricing issue

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines

Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …
robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …
Takeda oncology

Challenges in oncology R&D – part 2

November 25, 2015 Manufacturing and Production, Research and Development R&D, Takeda, oncology

Pharmafile put questions on the challenges pharma companies face when working in oncology R&D to Dixie-Lee Esseltine, vice president of …
Medicines Patent Pool

BMS and Medicines Patent Pool collaborate to increase Hep C medicine access

November 25, 2015 Manufacturing and Production, Research and Development Bristol-Myers Squibb, Medicines Patent Pool, daclatasvir, daklinza, hepatitis C

The Medicines Patent Pool (MPP) has announced its first licence for a hepatitis C medicine, signing an agreement with Bristol-Myers …
Arzerra

Genmab pulls plug on Phase III Arzerra trial

November 24, 2015 Manufacturing and Production, Research and Development Arzerra, Genmab, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma, ofatumumab, phase III, phase III failure

Genmab has stopped a Phase III study of its CD20-directed monoclonal antibody Arzerra, after it was shown to be unlikely …
Catapult cell therapy

Construction for new £55m cell and gene manufacturing centre in Stevenage begins

November 24, 2015 Manufacturing and Production Catapult, Cell Therapy Catapult, Hertfordshire, gene therapy, manufacturing, stevenage

The Government-backed Cell Therapy Catapult has begun the construction for its cell and gene therapy manufacturing centre.   The construction …
Beximco logo

FDA approves Beximco to manufacture Carvedilol for US

November 24, 2015 Manufacturing and Production Bangladesh, Beximco, Carvediol, FDA, exports, generics

Beximco Pharmaceuticals has become the first Bangladeshi pharma company to receive approval for a prescription drug to be manufactured in …
EU flag

Novartis and Amgen drugs signed-off by European Commission

November 24, 2015 Manufacturing and Production Amgen, Entresto, European Commission, Novartis, blincyto

The European governing body, the European Commission, has approved the Novartis drug Entresto for heart failure and Amgen’s Blincyto for …
NN Tianjin plant

Novo Nordisk to go green by 2020

November 24, 2015 Manufacturing and Production Novo Nordish, manufacturing, production, renewable energy

Novo Nordisk has announced plans to go green in the next five years by using only electricity from renewable sources …

OmniaMed UK appoints new senior management

November 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

OmniaMed has strengthened its senior management team by appointing Dr Clive Deverson as managing director and Dr Colin Griffin as …
merck-sharp--dohme-corp

MSD launches new antibiotic in the UK

November 23, 2015 Manufacturing and Production, Research and Development

Merck (MSD) has launched the new intravenous antibiotic Zerbaxa (ceftolozane/tazobactam) in the UK, for the treatment of complicated intra-abdominal infections …
tablets_red

Take the Pharmafocus reader survey today

November 23, 2015 Manufacturing and Production, Research and Development

As a valued reader of Pharmafocus, you regularly receive print copies of our market-leading newspaper and have access to the digital …
pfizer_hq_new_york_dark

Pfizer and Allergan confirm record $160 billion merger

November 23, 2015 Manufacturing and Production, Research and Development

Pfizer and Allergan have confirmed a $160 billion merger, unanimously approved by their boards of directors, creating the world’s largest …
The Gateway to Local Adoption Series

Latest content